Drug Profile
Lifibrol
Alternative Names: K 12148Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Klinge Pharma
- Developer Klinge Pharma; Merckle
- Class Antihyperlipidaemics; Benzamides; Small molecules
- Mechanism of Action Cholesterol synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercholesterolaemia